Haplotypes of NOS3 Gene Polymorphisms in Dilated Cardiomyopathy

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Matsa, Lova Satyanarayana ^a   Rangaraju, Advithi ^a   Vengaldas, Viswamitra ^a   Latifi, Mona ^a   Jahromi, Hossein Mehraban ^a   Ananthapur, Venkateshwari ^b   Nallari, Pratibha ^a  

^a OSMANIA UNIVERSITY   (India)

^b OSMANIA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE SYNTHASE;

ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DNA FLANKING REGION; EXON; GENE; GENE ACTIVITY; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENOTYPE; HAPLOTYPE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HUMAN; MAJOR CLINICAL STUDY; NOS3 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC DYSFUNCTION; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; ALLELES; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84880776340     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070523     Document Type: Article

References (27)

1. Cakir D, Mete N, (2010) The role of endothelial nitric oxide synthase gene polymorphism in clinically classified patients with coronary artery disease. Biotechnol & Biotechnol 24: 2117-2121.
2. Balligand JL, Feron O, Dessy C, (2009) eNOS Activation by Physical Forces: From Short-Term Regulation of Contraction to Chronic Remodeling of Cardiovascular Tissues. Physiol Rev 80: 481-534.
3. Fairchild TA, Fulton D, Fontana JT, Gratton JP, McCabe TJ, et al. (2001) Acidic hydrolysis as a mechanism for the cleavage of the Glu298Asp variant of human endothelial nitric-oxide synthase. J Biol Chem 276: 26674-26679.
4. Lembo G, De Luca N, Battagli C, Iovino G, Aretini A, et al. (2001) A common variant of endothelial nitric oxide synthase (glu298asp) is an independent risk factor for carotid atherosclerosis. Stroke 32: 735-740.
5. Doshi AA, Ziolo MT, Wang H, Burke E, Lesinski A, et al. (2010) A Promoter Polymorphism of the Endothelial Nitric Oxide Synthase Gene is Associated with Reduced mRNA and Protein Expression in Failing Human Myocardium. J Card Fail 16: 314-319.
6. Stein B, Eschenhagen T, Rüdiger J, Scholz H, Förstermann U, et al. (1998) Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure. J Am Coll Cardiol 32: 1179-1186.
7. McNamara DM, Holubkov R, Postava L, Ramani R, Janosko K, et al. (2003) Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure. Circulation 107: 1598-1602.
8. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, et al. (1998) A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 130: 65-69.
9. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, et al. (1999) A common variant of the endothelial nitric oxide synthase (Glu2983Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100: 1515-1520.
10. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE, (1996) A smokingdependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 2: 41-45.
11. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Ogawa H, et al. (2000) T-786C mutation in the 5′ flanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis. Am J Cardiol 86: 628-634.
12. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, et al. (1999) T-786-C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99: 2864-2870.
13. Scherrer-Crosbie M, Ullrich R, Bloch KD, Nakajima H, Nasseri B, et al. (2001) Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation 104: 1286-1291.
14. Ozhan H, Zungur M, Yazici M, Akdemir R, Gunduz H, et al. (2004) Angiotensin- converting enzyme, angiotensin II receptor, apolipoprotein E and endothelinal constitutive nitric oxide synthase gene polymorphisms in dilated cardiomyopathy. Turk Kardiyol Dern Ars 32: 295-301.
15. Lepic E, Burger D, Lu X, Song W, Feng Q, (2006) Lack of endothelial nitric oxide synthase decreases cardiomyocyte proliferation and delays cardiac maturation. Am J Physiol Cell Physiol 291: C1240-C1246.
16. Balligand JL, Cannon PJ, (1997) Nitric oxide synthases and cardiac muscle. Autocrine and paracrine influences. Arterioscler Thromb Vasc Biol 17: 1846-1858.
17. Habib F, Dutka D, Crossman D, Oakley CM, Cleland JGF, (1994) Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism?. Lancet 344: 371-373.
18. Satyanarayana ML, Advithi R, Venkateshwari A, Nallari P, (2009) Pro and Anti-Oxidants in Cardiomyopathy. Int J Hum Genet 9: 263-267.
19. Tiret L, Mallet C, Poirier O, Nicaud V, Millaire A, et al. (2000) Lack of Association between Polymorphisms of Eight Candidate Genes and Idiopathic Dilated Cardiomyopathy the CARDIGENE Study. J Am Coll Cardiol 35: 29-35.
20. Sandrim VC, Coelho EB, Nobre F, Arado GM, Lanchote VL, et al. (2006) Susceptible and protective eNOS haplotypes in hypertensive black and white subjects. Atherosclerosis 186: 428-432.
21. Wang J, Dudley D, Wang XL, (2002) Haplotype-specific effects on endothelial NO synthase promoter efficiency: modifiable by cigarette smoking. Arterioscler Thromb Vasc Biol 22: e1-e4.
22. Colombo MG, Paradossi U, Andreassi MG, Botto N, Manfredi S, et al. (2003) Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clinical Chemistry 49: 389-395.
23. McNamara DM, Tam SW, Sabolinski ML, Tobelmann P, Janosko K, et al. (2009) Endothelial nitric oxide synthase (nos3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial. J Card Failure 15: 191-198.
24. Brown G, Borutaite V, (2007) Nitric oxide and mitocondrial respiration in the heart. Cardiovasc Res 75: 283-290.
25. Lahiri DK, Nurnberger JI Jr, (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19: 5444.
26. Saremi MA, Saremi M, Tavallaei M, (2008) Rapid genomic DNA extraction (RGDE). Forensic Science International: Genetics Supplement Series 1: 63-65.
27. Nadaud S, Bonnardeaux A, Lathrop GM, Soubrier F, (1994) Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun 198: 1027-1033.